ArticleFrontiers in cardiovascular medicine2025
Predictors of recurrent ischemic stroke: anatomical characteristics of patent foramen ovale.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Percutaneous closure of patent foramen ovale (PFO) is effective in preventing PFO-related stroke recurrence. Considerable further research aimed at acquiring relevant data is needed to enable reliable identification of the subgroup of patients with PFO who would benefit from such closure. Objectives: This study aimed to select optimal candidates for PFO closure; we used echocardiography to assess various anatomical features of PFO, and then determined the value of those features for predicting recurrent PFO-related stroke. Methods: We used echocardiography to analyze selected anatomical characteristics of PFO, including atrial septal aneurysms (ASA), right-to-left shunts, PFO width, and tunnel length, in patients with PFO-related stroke. The participants underwent PFO closure, mostly plus medication, or medication-only and were followed up for at least 2 years. We compared the rates of recurrent stroke within 2 years between the two groups, and the anatomical characteristics of PFO between patients with and without recurrent stroke using mixed effects Cox models. Results: The study comprised 207 patients (120 males, 54.17%). Percutaneous PFO closure was successfully performed in 120 patients (PFO closure group), while 87 received medication-only therapy (medication-only group). After 2 years of follow-up, the risk of recurrent PFO-related ischemic stroke was was significantly lower in the PFO closure group (0.83%) than in the medication-only group (9.2%). The combination of anatomical features of ASA and large right-to-left shunts was associated with recurrent PFO-related stroke. Presence of an ASA alone was independently associated with recurrent PFO-related stroke (B = 2.43, hazard ratio = 11.37; 95% CI: 1.53-85.14; Conclusions: The anatomical features of ASA and large right-to-left shunts are associated with recurrent PFO-related stroke in patients with PFO. These patients may derive the most benefit from PFO closure because of the associated greater reduction in absolute risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.